NCT00029341View on ClinicalTrials.gov

A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Conditions

HIV Infections

Interventions

BEHAVIORAL

Treatment Interruption

Trial Locations (7)

37203

Comprehensive Care Clinic, Nashville

80262

Univ of Colorado Health Sciences Ctr, Denver

94110

San Francisco General Hosp, San Francisco

452670405

Univ of Cincinnati, Cincinnati

02906

Rhode Island Hosp, Providence

Stanley Street Treatment and Resource, Providence

The Miriam Hosp, Providence

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00029341 - A Study to Demonstrate That Anti-HIV Drug Therapy Can be Stopped Without Causing Viral Resistance, and to Characterize Drug Elimination From the Body | Biotech Hunter | Biotech Hunter